3,239 Shares in Humana Inc. (NYSE:HUM) Acquired by Liberty One Investment Management LLC

Liberty One Investment Management LLC acquired a new stake in shares of Humana Inc. (NYSE:HUM - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The fund acquired 3,239 shares of the insurance provider's stock, valued at approximately $822,000.

Other large investors have also recently made changes to their positions in the company. Clarius Group LLC boosted its holdings in Humana by 7.0% in the 4th quarter. Clarius Group LLC now owns 905 shares of the insurance provider's stock worth $230,000 after buying an additional 59 shares during the period. Canoe Financial LP purchased a new position in shares of Humana in the fourth quarter valued at about $62,000. Merit Financial Group LLC boosted its stake in shares of Humana by 16.6% in the fourth quarter. Merit Financial Group LLC now owns 1,819 shares of the insurance provider's stock worth $461,000 after acquiring an additional 259 shares during the period. Avanza Fonder AB purchased a new stake in shares of Humana during the fourth quarter worth about $2,524,000. Finally, Beech Hill Advisors Inc. bought a new stake in Humana during the 4th quarter valued at approximately $207,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company's stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 0.29% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on HUM shares. Bank of America upgraded Humana from an "underperform" rating to a "neutral" rating and upped their price target for the stock from $247.00 to $308.00 in a research note on Wednesday, November 6th. Oppenheimer dropped their target price on shares of Humana from $400.00 to $280.00 and set an "outperform" rating for the company in a research report on Thursday, October 3rd. Cantor Fitzgerald reiterated a "neutral" rating and issued a $395.00 price target on shares of Humana in a report on Tuesday, October 1st. UBS Group dropped their price objective on shares of Humana from $380.00 to $250.00 and set a "neutral" rating for the company in a report on Friday, October 4th. Finally, Morgan Stanley lifted their target price on Humana from $288.00 to $301.00 and gave the stock an "equal weight" rating in a report on Tuesday, December 17th. Twenty equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, Humana currently has a consensus rating of "Hold" and an average price target of $302.70.

Humana Trading Up 2.5 %

NYSE:HUM traded up $6.83 during mid-day trading on Monday, hitting $282.63. 1,829,765 shares of the stock traded hands, compared to its average volume of 1,581,703. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $415.73. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $34.03 billion, a price-to-earnings ratio of 25.03, a PEG ratio of 2.02 and a beta of 0.55. The firm's 50 day moving average is $273.81 and its two-hundred day moving average is $307.18.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping the consensus estimate of $3.48 by $0.68. The company had revenue of $29.30 billion for the quarter, compared to the consensus estimate of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. On average, equities research analysts predict that Humana Inc. will post 16.14 earnings per share for the current year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 annualized dividend and a dividend yield of 1.25%. Humana's dividend payout ratio is currently 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.